<?xml version="1.0" encoding="UTF-8"?>
<p>3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT), N-acetyl-L-cysteine (NAC), SB203580 (p38 inhibitor), lipopolysaccharide (LPS) and 2′,7′-dichlorofluorescein diacetate (DCFH-DA) were purchased from Sigma-Aldrich (Merck KGaA). The control, HO-1 (cat. no. sc-35555) and ATF3 (cat. no. sc-29758) small interfering RNAs (siRNAs) were purchased from Santa Cruz Biotechnology, Inc.</p>
